The FDA’s approval of Rocklatan and news updates from the American Glaucoma Society meeting were among the most-read glaucoma-related articles on Healio.com/OSN in recent weeks.
Here are the top five recent glaucoma stories:
FDA approves Rocklatan for open-angle glaucoma, ocular hypertension
A fixed-dose combination of netarsudil and latanoprost, Rocklatan — previously known as Roclatan — is designed to target the trabecular meshwork, which is considered the main cause of elevated IOP. Read more.
Kahook Dual Blade reduces IOP with and without phaco
The Kahook Dual